Chloe Shay
← Back to The Wallace H. Coulter Department of Biomedical Engineering
The Wallace H. Coulter Department of Biomedical Engineering
Chloe Shay works in Head and Neck Cancer Studies, Cancer, Hypoxia, and Metabolism, Cancer Cells and Metastasis, Fibroblast Growth Factor Research, Nanoparticle-Based Drug Delivery. Recorded institutional associations include Georgia Institute of Technology, Emory University, The Wallace H. Coulter Department of Biomedical Engineering.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Cancer metabolism and carcinogenesis
2024 · 138 citationsTargeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer
2020 · 129 citationsPFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism
2019 · 93 citationsFGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling
2017 · 85 citationsFGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
2018 · 80 citationsCell death shapes cancer immunity: spotlighting PANoptosis
2024 · 79 citationsPatterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
2023 · 69 citationsFGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression
2018 · 59 citationsSimultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
2019 · 57 citationsCombating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
2018 · 55 citationsNck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer
2019 · 49 citationsBlockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
2021 · 48 citationsHistone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
2019 · 46 citationsCircumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib
2020 · 42 citationsATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
2022 · 39 citationsSHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3
2021 · 34 citationsPGK1: An Essential Player in Modulating Tumor Metabolism
2021 · 34 citationsAutophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis
2018 · 32 citationsCombined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
2017 · 30 citationsTumor secretome shapes the immune landscape during cancer progression
2025 · 27 citationsATAD3A on the Path to Cancer
2019 · 26 citationsFGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis
2021 · 26 citationsImplications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report
2017 · 25 citationsAugmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
2017 · 23 citationsAdaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer
2023 · 18 citationsThe New Frontier of Three-Dimensional Culture Models to Scale-Up Cancer Research
2021 · 14 citationsPI3K Isoform-Selective Inhibitors in Cancer
2020 · 12 citationsUnveiling Tumor Microenvironment Interactions Using Zebrafish Models
2021 · 7 citationsExploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent
2024 · 5 citationsMultifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer
2021 · 3 citationsVisualizing and Evaluating Cancer Cell Growth and Invasion by a Novel 3D Culture System
2020 · 1 citationsEvaluating the Anticancer Activity of Natural Products Using a Novel 3D Culture Model
2021 · 1 citationsSupplementary Figure S4 from Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer
2023 · 1 citationsGlycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironment
2026 · 1 citationsRewiring tumor metabolism: heterogeneity, oncometabolites, and adaptive plasticity
2026 · 1 citationsAugmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
2017 · 0 citationsAbstract 853: Essential role of autocrine FGF19-FGFR4 signaling in head and neck tumorigenesis
2019 · 0 citationsAbstract 2114: Co-delivery nanoparticle to overcome therapeutic resistance in human head and neck cancer promoted by insufficient Src-targeted treatment
2019 · 0 citationsAbstract B09: Inactivating the EGFR-Arf1 axis by HDAC-targeted therapy to suppress invasiveness of head and neck squamous cell carcinoma
2020 · 0 citationsDevimistat induces reprogramming of glycolytic metabolism to augment its anticancer potency in head and neck cancer
2020 · 0 citationsAbstract PO-130: The mitochondrial protein ATAD3A promotes cisplatin resistance in oral squamous cell carcinoma
2020 · 0 citationsヒストン脱アセチル化酵素阻害剤はEGFR-Arf1軸のヒストンアセチル化非依存性遮断を介して頭頸部扁平上皮癌の攻撃性を抑制する【JST・京大機械翻訳】
2019 · 0 citationsAbstract 853: Essential role of autocrine FGF19-FGFR4 signaling in head and neck tumorigenesis
2019 · 0 citationsAbstract 2114: Co-delivery nanoparticle to overcome therapeutic resistance in human head and neck cancer promoted by insufficient Src-targeted treatment
2019 · 0 citationsAbstract 88: ATAD3A enhances head and neck cancer malignancy via mitochondrial ERK1/2 signaling
2022 · 0 citationsAbstract 3026: Inhibition of glutaminolysis overcomes metabolic adaptation to devimistat treatment
2022 · 0 citationsData from FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling
2023 · 0 citationsSupplementary Figure S5 from FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling
2023 · 0 citationsSupplementary Figure S1. from FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling
2023 · 0 citationsSupplementary Figure S2. from FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling
2023 · 0 citations
